Asthma Management

Asthma develops when the airways narrow, swell, and generate excess mucus, making breathing difficult. Allergies, air pollution, and other airborne irritants, other medical disorders, such as respiratory infections, exercise or physical activity, weather and air temperature, intense emotions, and some medications are among the most frequent asthma triggers.

Six essential areas of asthma treatment were the focus of the 2020 Asthma Management Guidelines: 

Focused Updates. Four or six locations are offered for treatment:

• Inhaled Corticosteroids
• Allergen Mitigation - For patients with asthma who are exposed and allergic to a specific indoor substance, the use of multiple strategies to reduce allergen exposure is conditionally recommended.
• Immunotherapy - Immunotherapy is conditionally recommended as an adjunct treatment for patients with mild to moderate allergic asthma who have demonstrated allergic sensitization and evidence of worsening asthma symptoms after exposure. 
• Long-Acting Muscarinic Agents - In patients 12 years or older with asthma not controlled by ICS alone, adding a LABA instead of a long-acting muscarinic agent to the ICS is recommended unless LABA therapy cannot be tolerated.

Stat Primary NP Clinic tries to incorporate the most update guidelines when treating or managing asthma.